Year archive

Optimind Pharma Corp. — 2025 filings

All 19 regulatory filings released by Optimind Pharma Corp. (OMND) in 2025, sourced directly from the official regulator.

19 Filings

2025 Period

2025 filings (19)

Filing	Released	Lang
News release - English.pdf M&A Activity	2025-09-08	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-07-30	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-07-30	English
Interim MD&A - English.pdf Management Reports	2025-07-30	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q2 2025	2025-07-30	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2025-06-28	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2025-06-28	English
Annual MD&A - English.pdf Management Reports	2025-06-28	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-06-28	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-06-28	English
Audited annual financial statements – English.pdf Audit Report / Information FY 2025	2025-06-28	English
Notice.pdf Capital/Financing Update	2025-05-07	English
Letter from former auditor.pdf Regulatory Filings	2025-05-07	English
Letter from successor auditor.pdf Regulatory Filings	2025-05-07	English
Notice.pdf Regulatory Filings	2025-05-07	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Capital/Financing Update	2025-01-29	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-01-29	English
Interim MD&A - English.pdf Management Reports	2025-01-29	English
Interim financial statements/report – English.pdf Interim / Quarterly Report 9M 2025	2025-01-29	English